RESUMEN
BACKGROUND: Mosquito biting frequency and how bites are distributed among different people can have significant epidemiologic effects. An improved understanding of mosquito vector-human interactions would refine knowledge of the entomological processes supporting pathogen transmission and could reveal targets for minimizing risk and breaking pathogen transmission cycles. METHODOLOGY AND PRINCIPAL FINDINGS: We used human DNA blood meal profiling of the dengue virus (DENV) vector, Aedes aegypti, to quantify its contact with human hosts and to infer epidemiologic implications of its blood feeding behavior. We determined the number of different people bitten, biting frequency by host age, size, mosquito age, and the number of times each person was bitten. Of 3,677 engorged mosquitoes collected and 1,186 complete DNA profiles, only 420 meals matched people from the study area, indicating that Ae. aegypti feed on people moving transiently through communities to conduct daily business. 10-13% of engorged mosquitoes fed on more than one person. No biting rate differences were detected between high- and low-dengue transmission seasons. We estimate that 43-46% of engorged mosquitoes bit more than one person within each gonotrophic cycle. Most multiple meals were from residents of the mosquito collection house or neighbors. People ≤ 25 years old were bitten less often than older people. Some hosts were fed on frequently, with three hosts bitten nine times. Interaction networks for mosquitoes and humans revealed biologically significant blood feeding hotspots, including community marketplaces. CONCLUSION AND SIGNIFICANCE: High multiple-feeding rates and feeding on community visitors are likely important features in the efficient transmission and rapid spread of DENV. These results help explain why reducing vector populations alone is difficult for dengue prevention and support the argument for additional studies of mosquito feeding behavior, which when integrated with a greater understanding of human behavior will refine estimates of risk and strategies for dengue control.
Asunto(s)
Aedes/virología , Dengue/transmisión , Conducta Alimentaria , Insectos Vectores/virología , Adolescente , Adulto , Animales , Niño , Femenino , Humanos , Mordeduras y Picaduras de Insectos , Masculino , TailandiaRESUMEN
BACKGROUND: Facial skin exhibits unique biophysical properties that are distinct from skin belonging to other areas of the body. Small to large regional differences in biophysical properties between facial sites are observed. Technological advances in dermatological research allow a quantitative study of the biophysical qualities of the face and its relation to skin elsewhere. However, comprehensive studies examining inter-regional variations using each of the six standard biophysical parameters have been few. We summarize findings on the biophysical parameters used to explore the human face as well as regional differences in skin reactivity to chemical irritants. METHODS: We performed a literature search using Pubmed, Embase, Science Citations Index, and the UCSF's dermatological library on biophysical parameters and skin physiology pertaining to the human face. RESULTS: Distinct regional differences in transepidermal water loss (TEWL), capacitance, blood flow, sebum, pH, and temperature were demonstrated in facial skin. However, studies cannot be compared with each other because each uses different anatomical sites, skin conditions, and measurement techniques. Intraregional differences in TEWL, sebum, and temperatures were observed on the cheeks and appeared to follow characteristic distribution patterns. Higher blood flow levels and skin temperatures were generally observed in areas with dense networks of blood vessels such as the nose and perioral region. Areas such as the forehead, nose, and chin consistently showed higher sebum casual levels, but variability in sebum levels between sites was also observed. The susceptibility of the face to hexyl nicotinate, sodium lauryl sulfate, and benzoic acid differed depending on location and age. CONCLUSION: Establishing a standardized biophysical profile of the human face will help to improve therapeutics, and further our understanding of differences in chemical reactivity and disease distribution. Future research necessitates standardization of the anatomical sites studied, sample size, and experimental protocols.
Asunto(s)
Biofisica , Cara/fisiología , Sebo/metabolismo , Piel/metabolismo , Agua/metabolismo , Capacidad Eléctrica , Humanos , Concentración de Iones de Hidrógeno , Flujometría por Láser-Doppler , Piel/irrigación sanguínea , Absorción Cutánea/fisiología , Pruebas de Irritación de la Piel , Temperatura Cutánea/fisiologíaRESUMEN
The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this study, we analyzed 31 cases of PLCIS (13 apocrine and 18 nonapocrine subtypes) and compared the clinical, pathologic, immunophenotypic, and genetic characteristics of these cases with those of 24 cases of CLCIS. Biomarker expression was examined using immunostaining for E-cadherin, gross cystic disease fluid protein-15, estrogen, progesterone, androgen receptor, human epidermal growth factor receptor2, CK5/6, and Ki67. Array-based comparative genomic hybridization to assess the genomic alterations was performed using microdissected formalin-fixed paraffin-embedded samples. Patients with PLCIS presented with mammographic abnormalities. Histologically, the tumor cells were dyshesive and showed pleomorphic nuclei, and there was often associated necrosis and microcalcifications. All lesions were E-cadherin negative. Compared with CLCIS, PLCIS showed significantly higher Ki67 index, lower estrogen receptor and progesterone receptor expression, and higher incidence of HER2 gene amplification. The majority of PLCIS and CLCIS demonstrated loss of 16q and gain of 1q. Apocrine PLCIS had significantly more genomic alterations than CLCIS and nonapocrine PLCIS. Although lack of E-cadherin expression and the 16q loss and 1q gain-array-based comparative genomic hybridization pattern support a relationship to CLCIS, PLCIS has clinical, mammographic, histologic, immunophenotypic, and genetic features that distinguish it from CLCIS. The histologic features, biomarker profile, and genomic instability observed in PLCIS suggest a more aggressive phenotype than CLCIS. However, clinical follow-up studies will be required to define the natural history and most appropriate management of these lesions.
Asunto(s)
Neoplasias de la Mama/patología , Carcinoma in Situ/patología , Carcinoma Lobular/patología , Adulto , Anciano , Anciano de 80 o más Años , Aneuploidia , Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/genética , Neoplasias de la Mama/metabolismo , Carcinoma in Situ/genética , Carcinoma in Situ/metabolismo , Carcinoma Lobular/genética , Carcinoma Lobular/metabolismo , Deleción Cromosómica , Cromosomas Humanos Par 1/genética , Cromosomas Humanos Par 16/genética , Hibridación Genómica Comparativa , ADN de Neoplasias/análisis , Femenino , Técnica del Anticuerpo Fluorescente Directa , Humanos , Procesamiento de Imagen Asistido por Computador , Técnicas para Inmunoenzimas , Inmunofenotipificación , Persona de Mediana Edad , Análisis de Secuencia por Matrices de OligonucleótidosRESUMEN
BACKGROUND/AIMS: The goal of this study was to determine the ability of two putative antioxidant solutions to suppress the formation of superoxide anion radicals created by optical excitation of a photosensitizer and measured by highly sensitive luminometric detection. METHODS/RESULTS: Solutions containing 3% antioxidant complex and 1% idebenone were tested. The antioxidant complex is an aqueous combination of botanical extracts rich in ferulic acid, caffeic acid, and other polyphenols. Idebenone is a lower molecular weight analog of coenzyme Q(10) (a potent antioxidant). Each was dissolved in lipid soluble reagents (solutions) and run through a Photochem (photochemiluminometer system) device. Their antioxidant capacity was expressed as nmol equivalents of synthetic vitamin E. Nine aliquots of each compound were measured. The mean antioxidant capacities for the 3% antioxidant complex and 1% idebenone were 525 +/- 23 and 213 +/- 14 nmol, respectively, with a statistically significant difference between the two compounds (P < 0.001). CONCLUSION: The 3% antioxidant solution possesses a significant antioxidative capacity, which was 2.5 times greater than the known antioxidant idebenone in a 1% solution as shown by the quenching of superoxide anion radicals measured by photochemiluminescence. This method provides rapid, accurate, and sensitive measurement of the antioxidant properties of lipid-soluble compounds.
Asunto(s)
Antioxidantes/química , Luminiscencia , Extractos Vegetales/química , Superóxidos/metabolismo , Ubiquinona/análogos & derivados , Ácidos Cafeicos/química , Ácidos Cumáricos/química , Flavonoides/química , Mediciones Luminiscentes , Fenoles/química , Polifenoles , Solubilidad , Superóxidos/análisis , Ubiquinona/química , Rayos Ultravioleta , Vitamina E/químicaRESUMEN
Array-based comparative genomic hybridization (CGH) is a technique that allows genome wide screening of gains and losses in DNA copy number. In cases where multiple tumors are encountered, this genetic technique may prove useful in differentiating new primary tumors from recurrences. In this case report, we used array-based CGH to examine the genomic relationships among two leiomyosarcomas and two breast cancers in the same patient, three of which were diagnosed synchronously. Array-based CGH was performed on the four tumor samples using random prime amplified microdissected DNA. Samples were hybridized onto bacterial artificial chromosome arrays composed of approximately 2400 clones. Patterns of alterations within the tumors were compared and genetic alterations among the leiomyosarcomas and breast lesions were found. Overall, three distinct genetic profiles were observed. While the two leiomyosarcomas shared a similar pattern of genetic alterations, the two invasive breast lesions did not. The nearly identical pattern of genetic alterations belonging to the two metachronous leiomyosarcomas confirmed metastatic recurrence while the two different genetic profiles of the invasive ductal carcinomas suggest that the two lesions represented two distinct foci of multifocal disease rather than clonal extension of the primary tumor. We conclude that genetic analysis by array-based CGH can clearly elucidate the relationships between multiple tumors and may potentially serve as an important clinical tool.